Aug 29 (Reuters) - Clinuvel Pharmaceuticals Ltd (CUV) :
- UNFRANKED FINAL DIVIDEND OF $0.02 PER ORDINARY SHARE HAS BEEN DECLARED
- FY NET PROFIT ATTRIBUTABLE UP 86% TO $13.2 MILLION
- FY REVENUES FROM ORDINARY ACTIVITIES UP 52% TO $25.8 MILLION
Source text: (bit.ly/2NzxTVO)
(([email protected];))
News: CUV Clinuvel Pharmaceuticals Posts FY Net Profit Attributable Of $13.2 Mln
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.28 |
Change
-0.250(1.85%) |
Mkt cap ! $741.1M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.62 | $13.25 | $1.157M | 86.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.42 | 228 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |
